Posts

Showing posts with the label buy malegra online

Many YouTube videos glorify alcohol

That's the finding of a study in September issue of the Journal of Studies on Alcohol and Drugs. Researchers looked at 137 YouTube videos that featured alcohol brands popular with underage drinkers -- from beer to vodka to cognac. Together, the videos had been viewed nearly 97 million times. Most often -- 40 percent of the time -- the videos were traditional advertisements. Others were "guides," in which a host showcased a particular alcohol, discussing its merits and offering serving suggestions. Some (10 percent) featured men showing off their "chugging" prowess. There is no way of knowing how many of those millions of viewers were underage kids, according to lead researcher Brian Primack, M.D., Ph.D., director of the University of Pittsburgh Center for Research on Media, Technology and Health. "Our aim is not to say we should be censoring this," said Primack, who is also dean of the Honors College and a professor of medicine and pediatric...

Football helmet smartfoam signals potential concussions in real time, study suggests

Image
BYU smartfoam in soccer helmets and pads. Credit score: BYU Photograph Most soccer followers have seen gamers get hit so onerous they'll barely stroll again to the sideline. All too typically, these gamers are again on the sector only a few performs later, regardless of struggling what seems to be a head damage. Whereas football-related concussions have been prime of thoughts lately, folks have struggled to create expertise to precisely measure them in actual time. Enter BYU mechanical engineering Ph.D. scholar, Jake Merrell, and a workforce of researchers throughout three BYU departments. Merrell and others have developed and examined a nano composite smartfoam that may be positioned inside a soccer helmet (and pads) to extra precisely take a look at the affect and energy of hits. ...

New genetic test for predicting cancer recurrence

Mitochondrial genes can be routinely checked in biopsies of patients diagnosed with many different cancer types, including breast, lung, ovarian or gastric cancers. And they prove more accurate than current methods of predicting a patient' s response to treatment. Scientists identified the new measures by looking at the expression levels of mitochondrial genes in samples from post-treatment cancer patients. "Early detection of cancer recurrence is everything; if we have information about a patient's prognosis we can act much more effectively," said Dr Michael P Lisanti, Professor of Translational Medicine at the University of Salford, and a co-author of the study. "You never know if cancer w ill return or how to prepare for that, so knowing who will and who won't respond well to treatment offers reassurance to doctors, patients and families, and allows a degree of closer monitoring." Professor Lisanti, who describes mitochondria as "t...